Bronchodilator response in patients with persistent allergic asthma could not predict airway hyperresponsiveness

Allergy, Asthma and Clinical Immunology

Volumn 3, Issue 4, 2007, Pages 123-127

  Petanjek, Bojana B ^a   Grle, Sanja P ^b   Pelicarić, Dubravka ^a   Vranković, Dubravka ^a  

^a Outpatient Centre for Diseases of the Respiratory System   (Croatia)

^b University Hospital for Lung Diseases Jordanovac   (Croatia)

Author keywords

Airway hyperresponsiveness; Allergic asthma; Bronchodilator response; Ipratropium bromide; Methacholine challenge testing; Salbutamol

Indexed keywords

IPRATROPIUM BROMIDE; METHACHOLINE; SALBUTAMOL;

ADOLESCENT; ADULT; AGED; ALLERGIC ASTHMA; ARTICLE; BRONCHODILATATION; BRONCHODILATING ACTIVITY; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MALE; OUTCOME ASSESSMENT; PERSISTENT ALLERGIC ASTHMA; PRICK TEST; PROGNOSIS; PROVOCATION TEST; SPIROMETRY; TREATMENT RESPONSE;

EID: 67650092979     PISSN: 17101484     EISSN: None     Source Type: Journal    
DOI: 10.2310/7480.2007.00009     Document Type: Article

References (24)

1. Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989; 83:1013-26.
2. Cockcroft DW, Davis BE. Mechanisms of airway hyperresponsiveness. J Allergy Clin Immunol 2006;118:551-9.
3. Bousquet J, Jeffery PK, Busse WW, et al. Asthma from bronchoconstiction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-45.
4. O'Byrne PM, Inman MD. Airway hyperresponsiveness. Chest 2003; 123 Suppl 3:411-6.
5. Fireman P. Understanding asthma pathophysiology. Allergy Asthma Proc 2003;24:79-83.
6. Bjornsdottir US, Cypcar DM. Asthma: an inflammatory mediator soup. Allergy 1999;54 Suppl 49:55-61.
7. Widdicombe JG. The neuronal component of asthma. Agents Actions Suppl 1989;28:213-24.
8. Douma WR, Gooijer de A, Rijcken B, et al. Lack of correlation between bronchoconstrictor response and bronchodilator response in a population based study. Eur Respir J 1997;10:2772-7.
9. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, workshop report. National Heart, Lung and Blood Institute and World Health Organization. Bethesda (MD): National Institutes of Health; 2006. NIH Publication No.: 96-3659 B.
10. Bernstein IL, Storms WW. Summary statements of practise parameters for allergy diagnostic tests. Ann Allergy Asthma Immunol 1995;75:543-52.
11. Nelson HS. Quality assurance in allergy skin testing. Ann Allergy 1993;71:3-4.
12. Report of the Working Party of the European Community for Coal and Steel. Standardization of Lung Function Tests. Bull Eur Physiopathol Respir 1983;19 Suppl 5:3-38.
13. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Eur Respir J 1993;6 Suppl 16:5-40.
14. Sterk PJ, Fabbri LM, Quanjer PH, et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J 1993;4 Suppl 16:53-83.
15. American Thoracic Society. Guidelines for methacholine and exercise challenge testing - 1999. Am J Respir Crit Care Med 2000; 161:309-29.
16. Scott GC, Braun SR. A survey of the current use and methods of analysis of bronchoprovocational challenges. Chest 1991;100:322-8.
17. Butorac-Petanjek B, Popović-Grle S, Pelicarić D, et al. Cholinergic tone and airway hyperresponsiveness in patients with persistent allergic asthma. Eur Respir J 2006;28 Suppl 50:219.
18. Chinn S, Burney PGJ, Britonn JR. Comparison of PD20 with two alternative measures of response to histamine challenge in epidemiological studies. Eur Respir J 1993;6:670-9.
19. Barnes PJ. Muscarinic receptor subtypes in airways (editorial; comments). Eur Respir J 1993;6:328-31.
20. Gosens R, Bos IS, Zaagsma J, et al. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med 2005;171:1096-102.
21. Rovati GE, Baroffio M, Citro S, et al. Cysteinyl-leukotrienes in the regulation of beta2-adrenoceptor function: an in vitro model of asthma. Respir Res 2006;7:103.
22. Martin JG, Ramos-Barbon D. Airway smooth muscle growth from the perspective of animal models. Respir Physiol Neurobiol 2003; 137:251-61.
23. Tsuji T, Kato T, Kimata M, et al. Differential effects of beta-2 adrenoreceptor desensitization on the Ig-E-dependent release of chemical mediators from cultured human mast cells. Biol Pharm Bull 2004;27:1549-54.
24. Yang XX, Ho G, Xu LJ, et al. The beta (2)-agonist salbutamol inhibits bronchoconstriction and leukotriene (D4) synthesis after dry gas hyperpnea in the guinea-pig. Pulm Pharmacol Ther 1999; 12:325-9.